Hua Chien Chen, Ph.D
Chief Executive Officer
Shu Jen Chen, Ph.D
Chief Scientific Officer
Joe Hsueh, MBA
Chief Operating Officer
Victor Chan, CFA, LLB, MBA
Chief Financial Officer
ACT Genomics is a world-leading cancer solution provider. We offer precision medicine services in Taiwan, Singapore, Hong Kong, and Japan. We combine experts of tumor biology, cancer genomics, and bioinformatics to provide treatment guidelines for solid tumors, relapse, drug resistance, as well as cancer monitoring, risk assessment, and immunotherapy evaluation. Through cutting-edge next-generation sequencing (NGS) platforms, bioinformatics analysis, and comprehensive service offerings, we are dedicated to turning every cancer patient’s genetic information into actionable resolutions.
Asian Genome Data Base
We integrate genomic databases information with Asia specific genome profiling.
Cutting-edge NGS Service Platform
We provide precise cancer genetic variants detection through minimum tumor samples through our ultra-sensitive NGS Platform.
Highest standard Lab with international accreditation
We are recognized and certified by the highest international standard CAP (NGS) accreditation, SNQ and more.
Professional Bioinformatics and Biomedical Team
We are strengthened by dozens of bioinformatics and biomedical professionals.
Integrated Comprehensive Cancer Services
We engage from every angle, preliminary research collaboration, international biopharma drug development, clinicians consultation and patient education.
The most valuable medical report and services
We deliver medical reports with genetic variants information, therapeutic implications and also provide comprehensive consultation services to empower physicians with evidence based-precise information.
Cancer is the second leading cause of death and estimated with 70% increase of newly diagnosed cases. Asia’s cancer death rate is higher than developed countries for delayed diagnosis and lack of treatment options (WHO 2017.2). Many of our people here at ACT Genomics are driven to make a difference in this battle with cancer by the experience of facing cancer at close range. Every one of us are devoted to this fight against cancer.
We truly believe that ACT Genomics can change the existing cancer treatment model and make cancer manageable. To enable patients and their family to walk through this journey of fighting cancer with dignity, precise comprehensive cancer management facilitates treatment with higher efficiency and accuracy
ACT Genomics entered joint venture with Canon Medical System
ACT Genomics Japan branch opening
ACT Genomics received Frost & Sullivan Product Line Strategy Leadership Award (Molecular Diagnostics)
Granted the Symbol of National Quality in Taiwan
ACT Genomics Hong Kong branch opening
ACT Genomics Shanghai branch opening
Acquired CAP (NGS) lab certification
ACT Genomics Singapore branch opening
Established bioinformatics platform
ACT Genomics NGS laboratory opening
ACT Genomics is an international leader in precision medicine, and we provide a broad range of career opportunities. See Job Openings
As a molecular information provider, we highly value our people. We know that the key to success is to use our passion to make a difference in the world. Therefore, we encourage our people to take initiative at every single step, to benefit our cancer patients and to improve ourselves every day. We help each other to grow and inspire each other for more innovative ideas. Together as a family, we are fearless. Dream big and take action, we never fight alone!